Current treatment landscape and emerging therapies for pancreatic cancer.

Related Articles Current treatment landscape and emerging therapies for pancreatic cancer. Am J Manag Care. 2019 01;25(1 Suppl):S3-S10 Authors: Adel N Abstract Pancreatic cancer remains a disease that is difficult to treat due to a typically late presentation, relatively high resistance to chemotherapy, and lack of effective targeted therapies. The standard of care relies on cytotoxic chemotherapy, primarily FOLFIRINOX and gemcitabine-based regimens. Dose modifications and/or the use of alternative combinations can reduce adverse effects, but these regimens remain highly toxic. As a result, long-term survival is low for patients with advanced or metastatic disease. There is a great need for…
Origen: Current treatment landscape and emerging therapies for pancreatic cancer. – PubMed